Chlordiazepoxide Hydrochloride Capsule
Product Images NDC 70518-0157

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride (NDC 70518-0157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Chlordiazepoxide HCI is a prescription drug available in capsule form with a 25 mg concentration. This medication is packaged in a quantity of 100 capsules and its source NDC is 00555-0159-02, while its repackaged NDC is 70518-0157-01. Teva, located in Frazer, PA is the manufacturer. The medication is classified as C-IV and is for RX only. Directives for usage can be found in the package insert. Caution is necessary as prescribed drugs should not be transferred to any individual other than the beneficiary, according to federal law. Store the medication at 15-30°C (50-86°F) [See USP] and keep it in a secure place that is out of the reach of children.*

FDA Label Image

Images 1

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.